This is a routine 10b5-1 plan sale by a director — no material signal. The sale is small relative to market cap and consistent with prior plan activity. No immediate trading action warranted.
Price Chart
Executive Summary
Director Elena Ridloff filed a Form 144 to sell 3,000 shares of Kymera Therapeutics common stock, with an estimated market value of approximately $258,240. The sale is planned for execution on May 11, 2026, and is part of a pre-arranged 10b5-1 trading plan, with prior sales under the same plan in March and April 2026. Given the small size relative to the company's $7.1B market cap and the use of a 10b5-1 plan, this filing is routine and carries minimal signal for traders.
Key Facts
- Insider: Director Elena Ridloff
- Shares to be sold: 3,000 shares of common stock
- Estimated value: $258,240
- Sale date: May 11, 2026
- Sale is part of a 10b5-1 trading plan established on December 11, 2025
- Prior sales under same plan: 4,600 shares on April 1, 2026 ($392,922) and 7,400 shares on March 31, 2026 ($631,739)
- Shares acquired via exercise of stock options (issuer grant, cash exercise)
Financial Impact
Approximately $258,240 in planned insider sales, representing ~0.004% of the company's $7.1B market cap
Risk Factors
- Insider selling under a 10b5-1 plan is pre-scheduled and not indicative of near-term negative views
- No additional risk from this filing alone
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-004332 |
| Document: 0001950047-26-004332-index.html | 0001950047-26-004332 |
| Document: 0001950047-26-004332.txt | 0001950047-26-004332 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 8w ago | 8-K | $105.48 $118.63 | ▲ +12.47% | ▲ +13.07% | $107.39 (+1.81%) |
Jul 8, 2026 12w ago | Insider Cluster | $114.16 $105.48 | ▲ +7.60% | ▲ +10.88% | $107.39 (+5.93%) |
Jul 2, 2026 13w ago | Insider Cluster | $113.51 $107.01 | ▲ +5.73% | ▲ +5.31% | $107.39 (+5.39%) |
Jul 2, 2026 13w ago | Insider Cluster | $113.51 $107.01 | ▲ +5.73% | ▲ +5.31% | $107.39 (+5.39%) |
Jun 30, 2026 13w ago | 144 | $114.20 $105.25 | ▲ +7.84% | ▲ +5.65% | $107.39 (+5.96%) |
Jun 29, 2026 13w ago | 144 | $114.67 $110.05 | ▼ −4.03% | ▼ −3.00% | $107.39 (−6.35%) |
Jun 26, 2026 13w ago | Insider Cluster | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 26, 2026 13w ago | 144 | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 26, 2026 13w ago | 144 | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 24, 2026 14w ago | 144 | $116.46 $110.38 | ▼ −5.22% | ▼ −5.75% | $107.39 (−7.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access